Nervous System Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Remitting relapsing multiple sclerosis (RRMS) patients who have no relapses over the past three months. ? Duration of illness had started not more than ten years. ? Age ranged from 20 to 45 years old. ? Body mass index (BMI) ranged from 18.5 to 24.9 kg/m2. ? Mini Mental State Examination (MMSE) score = 26. ? All the patients were ambulant with mild to moderate disability according to expanded disability status scale (EDSS) = 5. ? Primary fatigued MS patients complained from fatigue for more than two months with total score of Fatigue severity scale (FSS) = 36. ? All the patients educated with at least primary level of education.
Exclusion criteria
Exclusion criteria: ? Hamilton depression rating scale score (HDRS 17) = 7. ? Sleep disturbances with Epworth sleepiness scale (ESS) = 12. ? Severe visual or auditory impairment. ? Diseases that may affect cognitive functions such as hypertension, diabetes mellitus, connective tissue disorders, thyroid disorders, renal or hepatic impairment. ? Peripheral vestibulopathy. ? Patients on medications as glucocorticoids, amantadine, betaferon, hypnotics and modafinil. ? Previous history of any orthopedic problem.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Brain-derived neurotrophic factor (BDNF): As a family of proteins, neurotrophic factors, or “growth factors”, are directly involved in neuronal and synaptic growth. The BDNF protein is vital for cognitive performance in the short-term and for adaptations in brain morphology (e.g., plasticity) in the long-term. Indeed, the importance of BDNF for cognitive performance is a line of research that has been given a great amount of attention. Blood samples were taken from patients and controls to measure the serum level of brain-derived neurotrophic factor (BDNF). | — |
Secondary
| Measure | Time frame |
|---|---|
| - Pro-inflammatory cytokine tumor necrosis factor-a (TNF-a): Central fatigue is related to an increased level of pro-inflammatory cytokines, especially TNF-a. | — |
Countries
Egypt
Contacts
Associate Lecturer of Physical Therapy For Neurology Cairo University